Skip to main content
. 2021 Jul 12;8(1):e000528. doi: 10.1136/lupus-2021-000528

Figure 2.

Figure 2

Confidence of SLE diagnosis at T1 (panel A) and T2 (panel B) for patients who had a negative, low tier-2, high tier-2 or tier-1 multianalyte assay panel (MAP) score.